Sensory neurone responses to mucosal noxae in the upper gut: Relevance to mucosal integrity and gastrointestinal pain

Neurogastroenterology and Motility

Volumn 14, Issue 5, 2002, Pages 459-475

  Holzer, P ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cytokines; Efferent like function of afferent neurones; Gastric mucosal integrity; Gastrointestinal chemonociception; Mechanisms of hyperalgesia; Vanilloid receptors

Indexed keywords

CAPSAICIN; ION CHANNEL; TOXIC SUBSTANCE; VANILLOID RECEPTOR;

ABDOMINAL PAIN; BRAIN DEPTH STIMULATION; BRAIN STEM; DIGESTIVE SYSTEM INFLAMMATION; DYSPEPSIA; ENDOCRINE SYSTEM; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HYPERALGESIA; HYPERSENSITIVITY; IRRITABLE COLON; MECHANICAL STIMULATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SENSITIZATION; SENSORY NERVE CELL; STOMACH ACID; UPPER GASTROINTESTINAL TRACT; VAGUS NERVE STIMULATION;

ANIMALS; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL MUCOSA; NEURAL PATHWAYS; NEURONS, AFFERENT; RECEPTORS, DRUG; STIMULATION, CHEMICAL;

EID: 0036399085     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2002.00353.x     Document Type: Review

References (207)

1. Furness JB, Costa M. The Enteric Nervous System. Edinburgh: Churchill Livingstone, 1987.
2. Holzer P, Schicho R, Holzer-Petsche U, Lippe IT. The gut as a neurological organ. Wiener Klin Wochenschr 2001; 113: 647-60.
3. Furness JB, Clerc N. Responses of afferent neurons to the contents of the digestive tract, and their relation to endocrine and immune responses. Prog Brain Res 2000; 122: 159-72.
4. Holzer P, Michl T, Danzer M, Jocic M, Schicho R, Lippe IT. Surveillance of the gastrointestinal mucosa by sensory neurons. J Physiol Pharmacol 2001; 52: 505-21.
5. Furness JB, Kunze WAA, Bertrand PP, Clerc N, Bornstein JC. Intrinsic primary afferent neurons of the intestine. Prog Neurobiol 1998; 54: 1-18.
6. Grundy D, Scratcherd T. Sensory afferents from the gastrointestinal tract. In: Schultz SG, ed. Handbook of Physiology, Section 6: the Gastrointestinal System, Vol. I. Motility and Circulation, Part 1. Bethesda: American Physiological Society, 1989: 593-620.
7. Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994; 74: 95-138.
8. Sengupta JN, Gebhart GF. Gastrointestinal afferent fibers and sensation. In: Johnson, LR, ed. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press 1994: 483-519.
9. Berthoud H-R, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000; 85: 1-17.
10. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-93.
11. Kern MK, Shaker R. Cerebral cortical registration of subliminal visceral stimulation. Gastroenterology 2002; 122: 290-8.
12. Holzer P. Neural emergency system in the stomach. Gastroenterology 1998; 114: 823-39.
13. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The Functional Gastrointestinal Disorders, 2nd edn. McLean, VA, USA: Degnon Associates, 2000.
14. Brookes SJ. Classes of enteric nerve cells in the guinea-pig small intestine. Anat Rec 2001; 262: 58-70.
15. Schemann M, Reiche D, Michel K. Enteric pathways in the stomach. Anat Rec 2001; 262: 47-57.
16. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. IV. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol 2000; 278: G834-G838.
17. Szurszewski JH, Miller SM. Physiology of prevertebral ganglia. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press, 1994: 795-877.
18. Phillips RJ, Powley TL. Tension and stretch receptors in gastrointestinal smooth muscle: re-evaluating vagal mechanoreceptor electrophysiology. Brain Res Rev 2000; 34: 1-26.
19. Tong Q, Ma J, Kirchgessner AL. Vesicular glutamate transporter 2 in the brain-gut axis. Neuroreport 2001; 12: 3929-34.
20. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
21. Zheng H, Lauve A, Patterson LM, Berthoud H-R. Limited excitatory local effector function of gastric vagal afferent intraganglionic terminals in rats. Am J Physiol 1997; 273: G661-G669.
22. Zagorodnyuk VP, Chen BN, Brookes SJH. Intraganglionic laminar endings are mechano- transduction sites of vagal tension receptors in the guinea-pig stomach. J Physiol (London) 2001; 534: 255-68.
23. Jiang W, Kirkup AJ, Kreis M, Grundy D. Nicotinic activation of vagal afferent fibres supplying the rat jejunum: 'cross-talk' between the enteric and extrinsic innervation? Gastroenterology 2001; 120: A178.
24. Niijima A, Miyata G, Sato T, Meguid MM. Hepato-vagal pathway associated with nicotine's anorectic effect in the rat. Auton Neurosci Basic Clin 2001; 93: 48-55.
25. Takaki M, Nakayama S. Effects of capsaicin on myenteric neurons of the guinea pig ileum. Neurosci Lett 1989; 105: 125-30.
26. Cooke HJ, Reddix RA. Neural regulation of intestinal electrolyte transport. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press, 1994: 2083-132.
27. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 1995; 45: 1-98.
28. Holzer P, Barthó L. Sensory neurons in the intestine. In: Geppetti P, Holzer P, eds. Neurogenic Inflammation. Boca Raton: CRC Press, 1996: 153-67.
29. Mantyh CR, Pappas TN, Lapp JA et al. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 1996; 111: 1272-80.
30. Vanner S, Surprenant A. Neural reflexes controlling intestinal microcirculation. Am J Physiol 1996; 271: G223-G230.
31. Barthó L, Lénárd L, Lázár Z, Maggi CA. Connections between P2 purinoceptors and capsaicin-sensitive afferents in the intestine and other tissues. Eur J Pharmacol 1999; 375: 203-10.
32. Weber E, Neunlist M, Schemann M, Frieling T. Neural components of distension-evoked secretory responses in the guinea-pig distal colon. J Physiol (London) 2001; 536: 741-51.
33. Geppetti P, Holzer P, eds. Neurogenic Inflammation. Boca Raton: CRC Press, 1996.
34. Schicho R, Schemann M, Holzer P, Lippe IT. Mucosal acid challenge activates nitrergic neurons in myenteric plexus of rat stomach. Am J Physiol 2001; 281: G1316-G1321.
35. Castagliuolo I, LaMont JT, Letourneau R et al. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 1994; 107: 657-65.
36. Holzer P, Maggi CA. Dissociation of dorsal root ganglion neurons into afferent and efferent-like neurons. Neuroscience 1998; 86: 389-98.
37. Holzer P, Livingston EH, Guth PH. Sensory neurons signal for an increase in rat gastric mucosal blood flow in the face of pending acid injury. Gastroenterology 1991; 101: 416-23.
38. Raybould HE, Sternini C, Eysselein VE, Yoneda M, Holzer P. Selective ablation of spinal afferent neurons containing CGRP attenuates gastric hyperemic response to acid. Peptides 1992; 13: 249-54.
39. Ichikawa T, Ishihara K, Kusakabe T, Hiruma H, Kawakami T, Hotta K. CGRP modulates mucin synthesis in surface mucus cells of rat gastric oxyntic mucosa. Am J Physiol 2000; 279: G82-G89.
40. Akiba Y, Furukawa O, Guth PH, Engel E, Nastaskin I, Kaunitz JD. Sensory pathways and cyclooxygenase regulate mucus gel thickness in rat duodenum. Am J Physiol 2001; 280: G470-G474.
41. Akiba Y, Kaunitz JD. Regulation of intracellular pH and blood flow in rat duodenal epithelium in vivo. Am J Physiol 1999; 276: G293-G302.
42. Akiba Y, Guth PH, Engel E, Nastaskin I, Kaunitz JD. Acid-sensing pathways of rat duodenum. Am J Physiol 1999; 277: G268-G274.
43. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24.
44. Guo A, Vulchanova L, Wang J, Li X, Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1). relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 1999; 11: 946-58.
45. Michael GJ, Priestley JV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci 1999; 19: 1844-54.
46. Nozawa Y, Nishihara K, Yamamoto A, Nakano M, Ajioka H, Matsuura N. Distribution and characterization of vanilloid receptors in the rat stomach. Neurosci Lett 2001; 309: 33-6.
47. Anavi-Goffer S, McKay NG, Ashford ML, Coutts AA. Vanilloid receptor type 1- immunoreactivity is expressed by intrinsic afferent neurones in the guinea-pig myenteric plexus. Neurosci Lett 2002; 319: 53-7.
48. Pethö G, Jocic M, Holzer P. Role of bradykinin in the hyperaemia following acid challenge of the rat gastric mucosa. Br J Pharmacol 1994; 113: 1036-42.
49. Leung FW, Iwata F, Kao J, Seno K, Itoh M, Leung JWC. Role of bradykinin in acid-induced mesenteric hyperemia and duodenal villous damage. Life Sci 2002; 70: 779-90.
50. Lippe IT, Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol 1992; 105: 708-14.
51. 2 is attributable to sensitization of CRGP-containing sensory nerves. Gastroenterology 2001; 120: 134-43.
52. Schuligoi R, Jocic M, Heinemann A, Schöninkle E, Pabst MA, Holzer P. Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents. Gastroenterology 1998; 115: 649-60.
53. Holzer P, Lippe IT. Gastric mucosal hyperemia due to acid back-diffusion depends on splanchnic nerve activity. Am J Physiol 1992; 262: G505-G509.
54. Li D-S, Raybould HE, Quintero E, Guth PH. Calcitonin gene-related peptide mediates the gastric hyperemic response to acid back-diffusion. Gastroenterology 1992; 102: 1124-8.
55. Leung FW. Inhibition of spinal afferent nerve-mediated gastric hyperemia by nicotine: role of ganglionic blockade. Am J Physiol 1993; 264: H1087-H1092.
56. Holzer P, Wachter C, Jocic M, Heinemann A. Vascular bed-dependent roles of the peptide CGRP and nitric oxide in acid-evoked hyperaemia of the rat stomach. J Physiol (London) 1994; 480: 575-85.
57. Sharkey KA, Kroese ABA. Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat Rec 2001; 262: 79-90.
58. Holzer P. Gastric mucosal protection signaled by peptidergic afferent neurons. Drug News Perspect 1999; 12: 463-72.
59. Mózsik G, Abdel-Salam OME, Szolcsányi J. Capsaicin-Sensitive Afferent Nerves in Gastric Mucosal Damage and Protection. Budapest: Akadémiai Kiadó, 1997.
60. Yeoh KG, Kang JY, Yap I et al. Chili protects against aspirin-induced gastroduodenal mucosal injury in humans. Dig Dis Sci 1995; 40: 580-3.
61. Holzer P. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2000; 16: 469-78.
62. Yamamoto H, Horie S, Uchida M, Tsuchiya S, Murayama T, Watanabe K. Effects of vanilloid receptor agonists and antagonists on gastric antral ulcers in rats. Eur J Pharmacol 2001; 432: 203-10.
63. Michl T, Jocic M, Heinemann A, Schuligoi R, Holzer P. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 2001; 92: 19-27.
64. Miolan JP, Niel JP. The mammalian sympathetic prevertebral ganglia: integrative properties and role in the nervous control of digestive tract motility. J Auton Nerv Syst 1996; 58: 125-38.
65. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 2000; 81: 87-96.
66. Cervero F, Jänig W. Visceral nociceptors: a new world order? Trends Neurosci 1992; 15: 374-8.
67. Ozaki N, Gebhart GF. Characterization of mechanosensitive splanchnic nerve afferent fibers innervating the rat stomach. Am J Physiol 2001; 281: G1449-G1459.
68. Raybould HE. Nutrient tasting and signaling mechanisms in the gut. I. Sensing of lipid by the intestinal mucosa. Am J Physiol 1999; 277: G751-G755.
69. 3 receptor antagonists and antiemesis. In: King FD, Jones BJ, Sanger GJ, eds. 5-Hydroxytryptamine-3 Receptor Antagonists. Boca Raton: CRC Press, 1994: 255-317.
70. Beubler E. Serotonin as an intestinal secretagogue. In: Gaginella TS, Galligan JJ, eds. Serotonin and Gastrointestinal Function. Boca Raton: CRC Press, 1995: 85-108.
71. Buéno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997; 112: 1714-43.
72. Wachter CH, Heinemann A, Donnerer J, Pabst MA, Holzer P. Mediation by 5-hydroxytryptamine of the femoral vasoconstriction induced by acid challenge of the rat gastric mucosa. J Physiol (London) 1998; 509: 541-50.
73. Gershon MD. Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13 (Suppl. 2): 15-30.
74. Talley NJ. Serotoninergic neuroenteric modulators. Lancet 2001; 358: 2061-8.
75. Zhu JX, Wu XY, Owyang C, Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol (London) 2001; 530: 431-42.
76. Hillsley K, Grundy D. Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci Lett 1998; 255: 63-6.
77. Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 2000; 20: 3295-309.
78. Bertrand PP, Kunze WA, Furness JB, Bornstein JC. The terminals of myenteric intrinsic primary afferent neurons of the guinea-pig ileum are excited by 5-hydroxytryptamine acting at 5-hydroxytryptamine-3 receptors. Neuroscience 2000; 101: 459-69.
79. McLaughlin J, Grazia Luca M, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999; 116: 46-53.
80. Evangelista S, Maggi CA. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibres and CCK-A receptors. Br J Pharmacol 1991; 102: 119-22.
81. Heinemann A, Jocic M, Peskar BM, Holzer P. CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am J Physiol 1996; 270: G253-G258.
82. Takahashi T, Owyang C. Mechanism of cholecystokinin-induced relaxation of the rat stomach. J Auton Nerv Syst 1999; 75: 123-30.
83. Sayegh AI, Ritter RC. CCK-A receptor activation induces fos expression in myenteric neurons of rat small intestine. Regul Pept 2000; 88: 75-81.
84. Glatzle J, Kreis ME, Kawano K, Raybould HE, Zittel TT. Postprandial neuronal activation in the nucleus of the solitary tract is partly mediated by CCK-A receptors. Am J Physiol 2001; 281: R222-R229.
85. Sternini C, Wong H, Pham T et al. Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine. Gastroenterology 1999; 117: 1136-46.
86. Broberger C, Holmberg K, Shi TJ, Dockray G, Hökfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 2001; 903: 128-40.
87. Raybould HE, Hölzer H. Secretin inhibits gastric emptying in rats via a capsaicin-sensitive vagal afferent pathway. Eur J Pharmacol 1993; 250: 165-7.
88. Lu YX, Owyang C. Duodenal acid-induced gastric relaxation is mediated by multiple pathways. Am J Physiol 1999; 276: G1501-G1506.
89. 2 receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001; 121: 358-69.
90. Lembo T, Plourde V, Shui Z et al. Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil 1996; 8: 9-18.
91. Castro GA, Arntzen CJ. Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol 1993; 265: G599-G610.
92. Heppner FL, Christ AD, Klein MA et al. Transepithelial prion transport by M cells. Nat Med 2001; 7: 976-7.
93. Shanahan F. The intestinal immune system. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 3rd edn. New York: Raven Press, 1994: 643-84.
94. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997; 100: 6-10.
95. Castagliuolo I, Keates AC, Wang CC et al. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol 1998; 160: 6039-45.
96. Crabtree JE. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci 1998; 43: 46S-55S.
97. Kirkup AJ, Brunsden AM, Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol 2001; 280: G787-G794.
98. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001; 22: 146-52.
99. Young SH, Ennes HS, Steinhoff M, Mayer EA, Bunnett NW. Rat dorsal root ganglion (DRG) neurons express proteinase activated receptors (PARs) 1 and 2. Gastroenterology 2000; 118: A381.
100. Hoogerwerf WA, Zou L, Shenoy M et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001; 21: 9036-42.
101. Kirkup AJ, Bunnett NW, Grundy D. Characterisation of the PAR-2 activating peptide-induced mesenteric excitation. Neurogastroenterol Motil 2001; 13: 405.
102. Kawabata A, Kinoshita M, Nishikawa H et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 2001; 107: 1443-50.
103. Vergnolle N, Bunnett NW, Sharkey KA et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 2001; 7: 821-6.
104. Coelho AM, Vergnolle N, Wallace JL, Fioramonti J, Buéno L. Proteinase activating receptor-2 (PAR-2) activation produces delayed rectal hyperalgesia in awake rats. Neurogastroenterol Motil 2000; 12: 381.
105. 1 receptors are involved in proteinase-activated receptor-2-mediated visceral hyperalgesia in rats. Neurogastroenterol Motil 2001; 13: 395.
106. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1β: role of endogenous prostaglandins. J Neurosci 1998; 18: 9471-9.
107. 2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 2001; 276: 16083-91.
108. Haupt W, Jiang W, Kreis ME, Grundy D. Prostaglandin EP receptor subtypes have distinct effects on jejunal afferent sensitivity in the rat. Gastroenterology 2000; 119: 1580-9.
109. Maubach KA, Grundy D. The role of prostaglandins in the bradykinin-induced activation of serosal afferents of the rat jejunum in vitro. J Physiol (London) 1999; 515: 277-85.
110. 2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 1996; 75: 2361-8.
111. 3 in endotoxin-induced enhancement of pain perception. Biochem Pharmacol 2001; 62: 157-60.
112. Reimund JM, Wittersheim C, Dumont S et al. Increased production of tumour necrosis factor-α, interleukin-1b, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39: 684-9.
113. Galeazzi F, Haapala EM, van Rooijen N, Vallance BA, Collins SM. Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage-dependent. Am J Physiol 2000; 278: G259-G265.
114. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683-99.
115. Van Assche G, Barbara G, Deng Y, Lovato P, Gauldie J, Collins SM. Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. Gastroenterology 1999; 116: 346-53.
116. Fu LW, Longhurst JC. Interleukin-1β sensitizes abdominal visceral afferents of cats to ischaemia and histamine. J Physiol (London) 1999; 521: 249-60.
117. Gislason H, Rokke O, Svanes K. Release of cytokines associated with gastric mucosal injury. Eur Surg Res 1996; 28: 278-86.
118. Montuschi P, Tringali G, Mirtella A et al. Interleukin-1β release from rat gastric fundus. Am J Physiol 1996; 271: G275-G281.
119. Coimbra CR, Plourde V. Abdominal surgery-induced inhibition of gastric emptying is mediated in part by interleukin-1β. Am J Physiol 1996; 270: R556-R560.
120. Booth CE, Kirkup AJ, Hicks GA, Humphrey PA, Grundy D. Systemic bacterial lipopolysaccharide elicits acute sensitization of intestinal afferent nerves to chemical and mechanical stimuli in the rat. Gastroenterology 2001; 120: A71.
121. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF. Characterization of cytokine-induced hyperalgesia. Brain Res 1994; 654: 15-26.
122. Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Szekely M, Romanovsky AA. Signaling the brain in systemic inflammation, which vagal branch is involved in fever genesis? Am J Physiol 1998; 275: R63-R68.
123. Berthoud H-R, Kressel M, Raybould HE, Neuhuber WL. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol 1995; 191: 203-12.
124. Goehler LE, Gaykema RPA, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci Basic Clin 2000; 85: 49-59.
125. Berthoud H-R, Kressel M, Neuhuber WL. Vagal afferent innervation of the rat abdominal paraganglia as revealed by anterograde DiI-tracing and confocal microscopy. Acta Anat 1995; 152: 127-32.
126. Niijima A. The afferent discharges from sensors for interleukin 1β in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 1996; 61: 287-91.
127. Bucinskaite V, Kurosawa M, Miyasaka K, Funakoshi A, Lundeberg T. Interleukin-1β sensitizes the response of the gastric vagal afferent to cholecystokinin in rat. Neurosci Lett 1997; 229: 33-6.
128. Danzer M, Schicho R, Lippe IT, Holzer P. Facilitatory effect of intraperitoneal IL-1β and TNF-α on c-Fos expression in the brainstem after acid challenge of the rat gastric mucosa. Pharmacology 2001; 63: 241.
129. 2. Gastroenterology 2000; 118: A431.
130. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002; 25: 154-9.
131. Holzer P, Michl T, Jocic M, Heinemann A, Schuligoi R. Essential role of vagal afferents in the central signalling of a gastric mucosal acid insult. In: Krammer HJ, Singer MV, eds. Neurogastroenterology. From the Basics to the Clinics. Dordrecht: Kluwer, 2000: 697-707.
132. Traub RJ, Sengupta JN, Gebhart GF. Differential c-fos expression in the nucleus of the solitary tract and spinal cord following noxious gastric distention in the rat. Neuroscience 1996; 74: 873-84.
133. Liporace J, Hucko D, Morrow R et al. Vagal nerve stimulation: adjustments to reduce painful side effects. Neurology 2001; 57: 885-6.
134. Zagon A. Does the vagus nerve mediate the sixth sense? Trends Neurosci 2001; 24: 671-3.
135. Holzer P. Neural injury, repair, and adaptation in the GI tract. II. The elusive action of capsaicin on the vagus nerve. Am J Physiol 1999; 275: G8-G13.
136. Blackshaw LA, Dent J. Lower oesophageal sphincter responses to noxious oesophageal chemical stimuli in the ferret: involvement of tachykinin receptors. J Auton Nerv Syst 1997; 66: 189-200.
137. Partosoedarso ER, Blackshaw LA. Vagal efferent fibre responses to gastric and oesophageal mechanical and chemical stimuli in the ferret. J Auton Nerv Syst 1997; 66: 169-78.
138. Berthoud H-R, Patterson LM, Willing AE, Mueller K, Neuhuber WL. Capsaicin-resistant vagal afferent fibers in the rat gastrointestinal tract: anatomical identification and functional integrity. Brain Res 1997; 746: 195-206.
139. Blackshaw LA, Page AJ, Partosoedarso ER. Acute effects of capsaicin on gastrointestinal vagal afferents. Neuroscience 2000; 96: 407-16.
140. Bret-Dibat J-L, Creminon C, Couraud J-Y, Kelley KW, Dantzer R, Kent S. Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1β. Brain Res Bull 1997; 42: 443-9.
141. Bonaz B, Taché Y. Corticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of the hypothalamus. Brain Res 1997; 748: 12-20.
142. Malagelada JR. The continuing dilemma of dyspepsia. Aliment Pharmacol Ther 2001; 15 (Suppl 1): 6-9.
143. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
144. Hammer J, Talley NJ. Nonulcer dyspepsia. Curr Opinion Gastroenterol 2001; 17: 518-22.
145. Coffin B, Azpiroz F, Guarner F, Malagelada JR. Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994; 107: 1345-51.
146. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
147. Feinle C, Meier O, Otto B, D'Amato M, Fried M. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001; 48: 347-55.
148. Rhee PL, Kim YH, Son HJ et al. The etiologic role of gastric hypersensitivity in functional dyspepsia in Korea. J Clin Gastroenterol 1999; 29: 332-5.
149. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515-20.
150. Collen MJ, Loebenberg MJ. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 1989; 34: 246-50.
151. Coffin B, Chollet R, Flourié B et al. Intraluminal modulation of gastric sensitivity to distension. effects of hydrochloric acid and meal. Am J Physiol 2001; 280: G904-G909.
152. Allescher HD, Bockenhoff A, Knapp G, Wienbeck M, Hartung J. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36: 934-41.
153. 2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001; 15: 1291-9.
154. Read NW. Functional dyspepsia. a case of indecision. Gastroenterology 1999; 116: 761-2.
155. Kang JY, Yap I, Guan R, Tay HH, Math MV. Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic. Gut 1989; 30: 166-70.
156. Kang JY, Yap I. Acid and gastric ulcer pain. J Clin Gastroenterol 1991; 13: 514-6.
157. Fass R, Naliboff B, Higa L et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-73.
158. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-6.
159. Pimintel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503-6.
160. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-11.
161. Talley NJ, Butterfield JH. Mast cell infiltration and degranulation in colonic mucosa in the irritable bowel syndrome. Am J Gastroenterol 1996; 91: 1675-6.
162. 1 receptor gene. Neuroscience 2000; 98: 345-52.
163. Gschossmann JM, Coutinho SV, Miller JC et al. Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil 2001; 13: 229-36.
164. Bielefeldt K, Ozaki N, Gebhart GF. Mild gastritis alters voltage-sensitive sodium currents in gastric sensory neurons in rats. Gastroenterology 2002; 122: 752-661.
165. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119: 1276-85.
166. Coutinho SV, Plotsky PM, Sablad M et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol 2002; 282: G307-G316.
167. Holtmann G, Gschossmann J, Holtmann M, Talley NJ. H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci 2001; 46: 1550-7.
168. Bielefeldt K, Ozaki N, Gebhart GF. Experimental ulcers alter voltage-sensitive sodium currents in rat gastric sensory neurons. Gastroenterology 2002; 122: 394-405.
169. Chan J, Gonsalkorale WM, Perrey C et al. IL-10 and TGF-α genotypes in irritable bowel syndrome: evidence to support an inflammatory component? Gastroenterology 2000; 118: A184.
170. Cervero F, Laird JMA. Visceral pain. Lancet 1999; 353: 2145-8.
171. Sarkar S, Hobson AR, Furlong PL, Woolf CJ, Thompson DG, Aziz Q. Central neural mechanisms mediating human visceral hypersensitivity. Am J Physiol 2001; 281: G1196-G1202.
172. Holzer P. Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain. Eur J Pharmacol 2001; 429: 177-93.
173. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288: 1765-8.
174. Kaneko H, Mitsuma T, Uchida K, Furusawa A, Morise K. Immunoreactive somatostatin, substance P, and calcitonin gene-related peptide concentrations of the human gastric mucosa in patients with nonulcer dyspepsia and peptic ulcer disease. Am J Gastroenterol 1993; 88: 898-904.
175. Mönnikes H, Wollenberg B, Tebbe JJ, Dickhaus B, Arnold R, McGregor PG. Gastric pain thresholds and mucosal concentrations of sensory neuropeptides correlate in non-ulcer dyspepsia. Gastroenterology 2000; 118: A388.
176. Lewin GR. Neurotrophins and the specification of neuronal phenotype. Philos Trans R Soc Lond B Biol Sci 1996; 351: 405-11.
177. Bielefeldt K, Ozaki N, Gebhart GF. Nerve growth factor and sensitization of gastric afferent neurons. Digestion 2001; 63: 267-8.
178. Azpiroz F. Gastric neurology, evolving concepts and techniques. Eur J Gastroenterol Hepatol 1998; 10: 733-5.
179. Taché Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract. III. Stress- related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol 2001; 280: G173-G177.
180. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
181. Szallasi A. Vanilloid receptor ligands - hopes and realities for the future. Drugs Aging 2001; 18: 561-73.
182. Kuzhikandathil EV, Wang H, Szabo T, Morozova N, Blumberg PM, Oxford GS. Functional analysis of capsaicin receptor (vanilloid receptor subtype 1) multimerization and agonist responsiveness using a dominant negative mutation. J Neurosci 2001; 21: 8697-706.
183. Tominaga M, Caterina M, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21: 531-43.
184. Hwang SW, Cho H, Kwak J et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97: 6155-60.
185. Jordt SE, Tominaga M, Julius D. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 2000; 97: 8134-9.
186. Welch JM, Simon SA, Reinhart PH. The activation mechanism of rat vanilloid receptor 1 by capsaicin involves the pore domain and differs from the activation by either acid or heat. Proc Natl Acad Sci USA 2000; 97: 13889-94.
187. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agrò A, Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 2001; 276: 12856-63.
188. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000; 408: 985-90.
189. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001; 98: 6951-6.
190. Chuang HH, Prescott ED, Kong H et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5),P2-mediated inhibition. Nature 2001; 411: 957-62.
191. Mezey E, Toth ZE, Cortright DN et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000; 97: 3655-60.
192. Sanchez JF, Krause JE, Cortright DN. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 2001; 107: 373-81.
193. Szabo T, Biro T, Gonzalez AF, Palkovits M, Blumberg PM. Pharmacological characterization of vanilloid receptor located in the brain. Mol Brain Res 2002; 98: 51-7.
194. Akiba Y, Nakamura M, Ishii H. Immunolocalization of vanilloid receptor-1 (VR-1) in CGRP-positive neurons and interstitial cells of Cajal in the myenteric plexus of the rat gastrointestinal tract. Gastroenterology 2001; 120: A334.
195. Kulkarni-Narla A, Brown DR. Opioid, cannabinoid and vanilloid receptor localization on porcine cultured myenteric neurons. Neurosci Lett 2001; 308: 153-6.
196. 3) receptors in Hirschsprung's intestine. J Pediatr Surg 2001; 36: 1679-84.
197. Su X, Wachtel RE, Gebhart GF. Capsaicin sensitivity and voltage-gated sodium currents in colon sensory neurons from rat dorsal root ganglia. Am J Physiol 1999; 277: G1180-G1188.
198. Gonzalez R, Dunkel R, Koletzko B, Schusdziarra V, Allescher HD. Effect of capsaicin- containing red pepper sauce suspension on upper gastrointestinal motility in healthy volunteers. Dig Dis Sci 1998; 43: 1165-71.
199. Hammer J, Hammer HF, Eherer AJ, Petritsch W, Holzer P, Krejs GJ. Intraluminal capsaicin does not affect fluid and electrolyte absorption in the human jejunum but does cause pain. Gut 1998; 43: 252-5.
200. Rodriguez-Stanley S, Collings KL, Robinson M, Owen W, Miner PB. The effects of capsaicin on reflux, gastric emptying and dyspepsia. Aliment Pharmacol Ther 2000; 14: 129-34.
201. Urban L, Campbell EA, Panesar M et al. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain 2000; 89: 65-74.
202. Ikeda Y, Ueno A, Naraba H, Oh-ishi S. Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci 2001; 69: 2911-9.
203. Winter J. Brain derived neurotrophic factor, but not nerve growth factor, regulates capsaicin sensitivity of rat vagal ganglion neurones. Neurosci Lett 1998; 241: 21-4.
204. Winston J, Toma H, Shenoy M, Pasricha PJ. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 2001; 89: 181-6.
205. Yiangou Y, Facer P, Dyer NH et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001; 357: 1338-9.
206. Tohda C, Sasaki M, Konemura T, Sasamura T, Itoh M, Kuraishi Y. Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 2001; 76: 1628-35.
207. Bortolotti M, Coccia G, Grossi G. Red pepper and functional dyspepsia. N Engl J Med 2002; 346: 947-8.